Skip to Content

Mebrofenin

In the US, Mebrofenin (mebrofenin systemic) is a member of the drug class radiologic conjugating agents and is used to treat Diagnosis and Investigation.

US matches:

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0078266-06-5

Chemical Formula

C15-H19-Br-N2-O5

Molecular Weight

387

Therapeutic Category

Diagnostic agent, liver function

Chemical Name

Glycine, N-[2-[(3-bromo-2,4,6-trimetylphenyl)amino]-2-oxoetyl]-N-(carboxymetyl)-

Foreign Names

  • Mebrofeninum (Latin)
  • Mebrofenin (German)
  • Mébrofenine (French)
  • Mebrofenina (Spanish)

Generic Names

  • Mebrofenin (OS: USAN, BAN)
  • Mébrofénine (OS: DCF)
  • SQ 26962 (IS: Squibb)
  • Mebrofenin (PH: USP 38)

Brand Names

  • Bridatec
    GE Healthcare, Malta; GE Healthcare, Netherlands

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide